Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lorch

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
European Urology|November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial CarcinomaRichard Cathomas, Anja Lorch, Harman M Bruins, et al.
Praxis|May 28, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate CancerArnoud J Templeton, Vérane Achard, Dilara Akhoundova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer GroupDarren R Feldman, Anja Lorch, Andrew Kramar, et al.
European Urology|September 27, 2023
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)Viktor Grünwald, Philipp Ivanyi, Stefanie Zschäbitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
European Urology|March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
European Urology|November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial CarcinomaRichard Cathomas, Anja Lorch, Harman M Bruins, et al.
Praxis|May 28, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate CancerArnoud J Templeton, Vérane Achard, Dilara Akhoundova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer GroupDarren R Feldman, Anja Lorch, Andrew Kramar, et al.
European Urology|September 27, 2023
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)Viktor Grünwald, Philipp Ivanyi, Stefanie Zschäbitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
European Urology|March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Pageof 8